Variant microorganism producing 5-aminolevulinic acid and method for preparing 5-aminolevulinic acid using therof
AssigneeKorea University Research and Business Foundation
InventorsSung Ok Han, Seung-Kyou You, Jeong-Eun Hyeon, Young-jin Ko
Life of this patent
Estimating the term…
Abstract
The present invention relates to a mutant microorganism having the ability to produce 5-aminolevulinic acid, and more particularly, to a mutant microorganism having the ability to produce 5-aminolevulinic acid wherein a glutamyl-tRNA reductase-encoding gene is introduced in a glutamic acid-producing microorganism, and to a method for producing 5-aminolevulinic acid using the same. According to the present invention, 5-aminolevulinic acid that is useful in the medical or agricultural field can be produced in a significantly higher yield than that of conventional production methods.
Claims2
A method for producing 5-aminolevulinic acid, comprising the steps of:
- (a) culturing in a medium comprising glucose and penicillin G, a mutant microorganism having the ability to produce 5-aminolevulinic acid, wherein the mutant microorganism is a glutamic acid-producing microorganism and is transformed with a gene encoding a mutant glutamyl tRNA reductase, wherein the mutant glutamyl tRNA reductase comprises the amino acid sequence of SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9, or SEQ ID NO:
- 10, except for an insertion of two lysines between residues 2 and 3 of the respective sequence, thereby producing 5-aminolevulinic acid;
- and
- (b) recovering the produced 5-aminolevulinic acid,
- wherein the mutant microorganism has an increased ability to produce 5-aminolevulinic acid as a result of the presence of the penicillin G in the medium, as compared to production of 5-aminolevulinic acid by the mutant microorganism in a corresponding medium lacking said penicillin G.
A method for producing 5-aminolevulinic acid, comprising the steps of:
- (a) culturing in a medium comprising glucose and penicillin G, a mutant microorganism having the ability to produce 5-aminolevulinic acid, wherein the mutant microorganism is a glutamic acid-producing microorganism and is transformed with a gene encoding a mutant glutamyl tRNA reductase, wherein the mutant glutamyl tRNA reductase comprises the amino acid sequence of SEQ ID NO:
- 6, SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9, or SEQ ID NO:
- 10, except for an insertion of two lysines between residues 2 and 3 of the respective sequence, and wherein the mutant microorganism is further transformed with a gene encoding glutamate-1-semialdehyde aminotransferase, thereby producing 5-aminolevulinic acid;
- and
- (b) recovering the produced 5-aminolevulinic acid,
- wherein the mutant microorganism has an increased ability to produce 5-aminolevulinic acid as a result of the presence of the penicillin G in the medium, as compared to production of 5-aminolevulinic acid by the mutant microorganism in a corresponding medium lacking said penicillin G.
Dependencies are inferred from the claim text.